UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000018050 |
|---|---|
| Receipt number | R000020659 |
| Scientific Title | International survey on the present status of integrative medicine and the approach for it. |
| Date of disclosure of the study information | 2015/07/01 |
| Last modified on | 2017/06/25 11:40:32 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
International survey on the present status of integrative medicine and the approach for it.
Acronym
International survey of integrative medicine
Scientific Title
International survey on the present status of integrative medicine and the approach for it.
Scientific Title:Acronym
International survey of integrative medicine
Region
| Japan | Asia(except Japan) | North America |
| South America | Europe | Africa |
Condition
Condition
adults aged 30 years or older with/without apparent illness
Classification by specialty
| Not applicable | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate the present status of integrative medicine and the approach for it in approximately 20 countries.
Basic objectives2
Others
Basic objectives -Others
To consider the concept and the goal of integrative medicine
Trial characteristics_1
Exploratory
Trial characteristics_2
Pragmatic
Developmental phase
Not applicable
Assessment
Primary outcomes
the similarity and the difference of integrative medicine between countries
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 30 | years-old | <= |
Age-upper limit
| 80 | years-old | > |
Gender
Male and Female
Key inclusion criteria
1. Those living in the relevant country for 10 years or more.
2. Those who are interested in integrative medicine.
Key exclusion criteria
1. Those who do not understand the meaning of this study.
2. Those who cannot answer the questionnaire of their own accord.
3. Those who are considered to be inappropriate as a participant.
Target sample size
1500
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Kiyoshi Suzuki |
Organization
Gyokusenkai MOA Takanawa Clinic
Division name
President
Zip code
Address
4-8-10 Takanawa, Minato-ku, Tokyo
TEL
03-5421-1945
k.suzuki@mhs.or.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Kiyoshi Suzuki |
Organization
Gyokusenkai MOA Takanawa Clinic
Division name
President
Zip code
Address
4-8-4-8-10 Takanawa, Minato-ku, Tokyo
TEL
03-5421-1945
Homepage URL
k.suzuki@mhs.or.jp
Sponsor or person
Institute
MOA Health Science Foundation, the general incorporated foundation
Institute
Department
Personal name
Funding Source
Organization
MOA Health Science Foundation, the general incorporated foundation
Organization
Division
Category of Funding Organization
Non profit foundation
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2015 | Year | 07 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Terminated
Date of protocol fixation
| 2015 | Year | 06 | Month | 23 | Day |
Date of IRB
Anticipated trial start date
| 2015 | Year | 07 | Month | 01 | Day |
Last follow-up date
| 2017 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
| 2017 | Year | 12 | Month | 31 | Day |
Date trial data considered complete
| 2017 | Year | 12 | Month | 31 | Day |
Date analysis concluded
| 2018 | Year | 02 | Month | 28 | Day |
Other
Other related information
1. The team delivers a lecture to volunteer investigators in the relevant countries, explaining the purposes of the study and giving guidance on how to administer the questionnaires.
2. The investigators explain the meaning of this study to the participants, preferably government officers or doctors, and obtain the answer of the questionnaire.
Management information
Registered date
| 2015 | Year | 06 | Month | 23 | Day |
Last modified on
| 2017 | Year | 06 | Month | 25 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020659
